Clinical Trial Update: Clinical Study on the Treatment of Type I Neurofibromatosis With Smeitinib Hydrosulfate Capsule [Phase 2]

View source ↗

Summary

This Clinical Trial Update indicates a Phase 2 study evaluating smeitinib hydrosulfate capsules for Neurofibromatosis type 1, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Drugs mentioned

• Smeitinib Hydrosulfate Capsule (smeitinib hydrosulfate)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Neurofibromatosis 1 | Phase 2 | Status: NOT_YET_RECRUITING